Association of aspirin use with improved 5-year survival in colorectal cancer patients with PIK3CA mutation

被引：0
|
作者：
Kothari, Nishi
Yeatman, Timothy Joseph
Fisher, Kate
Schell, Michael J.
Kim, Richard D.
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL 33612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3644
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
    Liao, Xiaoyun
    Lochhead, Paul
    Nishihara, Reiko
    Morikawa, Teppei
    Kuchiba, Aya
    Yamauchi, Mai
    Imamura, Yu
    Qian, Zhi Rong
    Baba, Yoshifumi
    Shima, Kaori
    Sun, Ruifang
    Nosho, Katsuhiko
    Meyerhardt, Jeffrey A.
    Giovannucci, Edward
    Fuchs, Charles S.
    Chan, Andrew T.
    Ogino, Shuji
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (17): : 1596 - 1606
  • [2] Aspirin, PIK3CA Mutation, and Colorectal-Cancer Survival REPLY
    Ogino, Shuji
    Liao, Xiaoyun
    Chan, Andrew T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (03): : 289 - 290
  • [3] PIK3CA mutation is predictive of poor survival in patients with colorectal cancer
    Kato, Shunsuke
    Iida, Satoru
    Higuchi, Tetsuro
    Ishikawa, Toshiaki
    Takagi, Yoko
    Yasuno, Masamichi
    Enomoto, Masayuki
    Uetake, Hiroyuki
    Sugihara, Kenichi
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (08) : 1771 - 1778
  • [4] Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation
    Kothari, Nishi
    Kim, Richard
    Jorissen, Robert N.
    Desai, Jayesh
    Tie, Jeanne
    Wong, Hui-Li
    Farragher, Ian
    Jones, Ian
    Day, Fiona L.
    Li, Shan
    Sakthinandeswaren, Anuratha
    Palmieri, Michelle
    Lipton, Lara
    Schell, Michael
    Teer, Jamie K.
    Shibata, David
    Yeatman, Timothy
    Sieber, Oliver M.
    Gibbs, Peter
    Tran, Ben
    [J]. ACTA ONCOLOGICA, 2015, 54 (04) : 487 - 492
  • [5] Aspirin use and survival outcomes in patients (pts) with PIK3CA mutant colorectal cancer (CRC)
    Ben Tran
    Jorissen, Robert N.
    Desai, Jayesh
    Day, Fiona
    Lipton, Lara Rachel
    Wong, Hui-Li
    Tie, Jeanne
    Faragher, Ian
    Jones, Ian
    Sieber, Oliver
    Gibbs, Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Aspirin Therapy for Colorectal Cancer With PIK3CA Mutation: Simply Complex!
    Fuchs, Charles S.
    Ogino, Shuji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4358 - 4361
  • [7] Aspirin and PIK3CA Mutations in Colorectal Cancer
    Kirstein, M. M.
    Vogel, A.
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (03): : 306 - 307
  • [8] PIK3CA mutation and colorectal cancer precision medicine
    Hamada, Tsuyoshi
    Nowak, Jonathan A.
    Ogino, Shuji
    [J]. ONCOTARGET, 2017, 8 (14) : 22305 - 22306
  • [9] Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer
    Stec, Rafal
    Semeniuk-Wojtas, Aleksandra
    Charkiewicz, Radoslaw
    Bodnar, Lubomir
    Korniluk, Jan
    Smoter, Marta
    Chyczewski, Lech
    Niklinski, Jacek
    Szczylik, Cezary
    [J]. ONCOLOGY LETTERS, 2015, 10 (03) : 1423 - 1429
  • [10] PIK3CA mutation, aspirin use after diagnosis, and colorectal cancer survival: A systematic review and meta-analysis of epidemiological studies
    Paleari, Laura
    Puntoni, Matteo
    Clavarezza, Matteo
    Caviglia, Silvia
    Corradengo, Davide
    Campazzi, Eleonora
    Provinciali, Nicoletta
    De Censi, Andrea
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345